Clinical Trial Update: A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ALT-836 in combination with Gemcitabine for locally advanced or metastatic solid tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• ALT-836 (anti-tissue factor antibody)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Altor BioScience | Conditions: Locally Advanced Malignant Neoplasm, Malignant Solid Tumour | Phase 1 | Status: COMPLETED